Do you want to know the latest information and news about today's important healthcare topics? Join the conversation with The Point, CMDA's blog focusing on breaking news stories in bioethics and healthcare. CMDA's experts contribute to the blog and also recommend additional resources and information.
The purpose of this blog is to stimulate thought and discussion about important issues in healthcare. Opinions expressed are those of the author and do not necessarily express the views of CMDA. We encourage you to join the conversation on our website and share your experience, insight and expertise. CMDA has a rigorous and representative process in formulating official positions, which are largely limited to bioethical areas.
On August 4, 2022, the U.S. Department of Health and Human Services (HHS) published its notice of proposed rulemaking (NPRM) to the Federal Registry to modify Section 1557, the “Nondiscrimination in Health Programs and Activities Clause” of the Affordable Care Act.
During my surgical training, I helped care for an aging professor who bemoaned his declining health. His mind still moved in academic circles, pondering the high points of chemistry and physics, but arthritis had so fused the bones in his neck that he couldn’t nestle into a pillow anymore. Cancer riddled his chest, and squandered nutrients, until his frame wasted to skeletal proportions. The simple routine of enjoying a meal pitched him into coughing, and pneumonia festered from the secretions that pooled in his lungs.
Today I am a pharmacist. Well, not really. I’m still a physician, but this week in the Dominican Republic on a Global Health Outreach (GHO) trip, I am serving as a pharmacist. The incredibly dedicated pharmacist who has served on this team for years is at home with COVID-19, and I am attempting to fill his shoes. And as I look around the pharmacy, I see a beautiful picture. While we don’t quite represent every tribe and tongue, we are a varied group, to be sure. There is a woman here from Georgia who is originally from Colombia, a woman here from Ohio who is originally from Indonesia and a multitude of Dominicans and Americans. When I look outside the pharmacy door at the rest of our 75+ team members, we represent at least 10 U.S. states and at least five countries of origin. We include physicians, dentists, nurses, students, optometrists, teachers, pastors and homeschooling moms. We span ages from 10 to 70. We have people triaging and organizing patients, taking vitals, pulling teeth, prescribing medications, performing ultrasounds, filling prescriptions, dancing, singing, making balloon animals and sharing the gospel. We speak English, Spanish, Indonesian and Tagolog. We are funded by people and churches who paid our way or bought medications, and we are even funded by airlines that waived baggage fees to allow the many bags of equipment to travel here. We are supported in prayer by hundreds of people across at least two countries. As a group, we exemplify the beauty of the body of Christ.
The June 28, 2022 piece by Rita Rubin in the Medical News & Perspectives section of JAMA, “How Abortion Bans Could Affect Care for Miscarriage and Infertility,” presents a one-sided narrow view of the potential impact of the U.S. Supreme Court’s ruling on women’s reproductive care, specifically the management of miscarriages and advanced reproductive technologies.
Sometimes, we need a “right now” word. Sometimes, this is referred to as a “rhema word” or “God’s Word spoken to you.”
Supporters of gender-affirming therapy (GAT)—transition affirmation—are doubling down on claims that regret and detransition are rare. From state-level bills in my home state of California to national policy initiatives from the federal administration, the assertion that transitioning for gender dysphoria is all but regret free is used as a promotional tool for the proposed mandating of GAT essentially on request. However, the sales pitch does not hold up to inspection.
CMDA’s Advocacy Department is focused on serving as your voice to the government, media and public on bioethical and public policy issues. Much of the grassroots advocacy efforts we take on both federal and state levels depend on your individual involvement.
Over the years, countless healthcare professionals have shared touching stories of mentors who encouraged and inspired them at early stages of their training. Such accounts motivate us to “pay it forward” and serve in that role for the next generation.
At the time of this writing, the official U.S. Supreme Court ruling on the possible overturn of Roe v. Wade is still pending. The contents of the leaked Samuel Alito document stating that the right to an abortion is not ensconced in the Constitution is still in draft form.
In a conclusion to a case that has gripped the nation, on May 13, 2022 a judge in Tennessee sentenced former nurse RaDonda Vaught to three years’ probation with a judicial diversion, rather than a maximum sentence of 8 years in prison, for clinically negligent homicide.
Do you remember your high school, college or medical/dental school graduation? Probably a bit, I suppose, but if you’re like me, those days are a bit of a blur. How about the graduation speaker at each of those events? Do you remember what was said?
As a former federal government employee, I have observed firsthand how policies affecting our everyday lives are often crafted and administered by unelected federal bureaucrats. Coupled with presidential executive orders, this gives the executive branch a remarkable amount of power. Within the executive branch exists the regulatory framework, which is overseen by a little-known office under the purview of the White House called the Office of Information and Regulatory Affairs. Proposed actions from this office are published in the “Unified Agenda” twice a year in the spring and fall, giving the public a glimpse into what future regulatory action is on the horizon. Most of us are unaware (some may say blissfully so) of the volume of regulatory and deregulatory actions under development and review in more than 60 federal departments, agencies and commissions across the government. To give some perspective, the U.S. Department of Health and Human Services (HHS) currently has more pending actions than any other cabinet level department, which underscores the sheer size and reach of this titan agency with a budget that surpasses the gross national product of several countries!
The Point Commentaries:
Sorry, we couldn't find any posts. Please try a different search.